ConCallIQ
Go Pro
Home › Entero Healthcare Solutions › Margin Trend

Entero Healthcare Solutions Margin Trend — Quarter by Quarter

Entero Healthcare Solutions's EBITDA margin moved from 4.0% in Q1 FY26 to 4.0% in Q4 FY26 across 3 quarters. Management commentary below explains the cost and pricing drivers mentioned on calls.

EBITDA Margin by Quarter

QuarterEBITDA Margin (%)YoY Change
Q4 FY264.0%+67 bps
Q3 FY264.0%+30 bps
Q1 FY264.0%+82 bps

What management said about ebitda margin

G

Q4 FY26 · FY27 EBITDA margin target of 5%

EBITDA margin guided to 5% for FY27, up from 4% in FY26, supported by gross margin expansion and operating leverage.

G

Q4 FY26 · Operating cash flow conversion of at least 50% of EBITDA

Target to convert at least 50% of EBITDA into operating cash flow in FY27, reflecting working capital discipline.

G

Q3 FY26 · Full-year EBITDA margin above 4%

EBITDA margin guidance of north of 4% for FY26, requiring Q4 margin of ~4.5% to achieve.

G

Q3 FY26 · Medtech acquisitions to add 50-75bps to EBITDA margins

Post-integration, medtech acquisitions expected to improve overall EBITDA margin by 50-75 basis points on a pro forma basis.

G

Q1 FY26 · 4%+ EBITDA margin for FY26

Full-year EBITDA margin target of over 4%, driven by operating leverage, product mix improvement, and procurement efficiencies.